GENCINIA Aids Diabetics
January 18, 2008 - News
Comments

ANAHEIM, Calif.— A proprietary extract of Coccinia cordifolia (syn. Coccinia indicia) may help patients with type 2 diabetes control their blood sugar and lower cholesterol (Diabetes Care. ePub ahead of print). In a double blind, placebo-controlled, randomized clinical trial conducted at the Institute of Population Health and Clinical Research, Bangalore, India, 60 patients with mild diabetes received 1 g/d of C. cordifolia extract (as GENCINIA™, from Gencor Pacific) for 90 days. Patients receiving the extract had a significant decrease in fasting and postprandial blood glucose, decreasing by 16 percent and 18 percent, respectively, at 90 days. Intervention also reduced levels of glycosylated hemoglobin, low-density lipoprotein (LDL) cholesterol and triglycerides, though the reductions were not statistically significant.

Comments
comments powered by Disqus
Related News
News
Bioactives American Corporation's Salsulin was announced as the first GRAS-certified S. oblanga
Article
Blake Ebersole
Article
Article
Celeste Sepessy
News
Gencor entered the probiotics market with its new Intelicaps® technology, which embeds probiotics